Healthcare Professionals
Dynamic Decompression for Heart Failure
CORVIA® ATRIAL SHUNT SYSTEM
The Corvia Atrial Shunt is a novel, minimally invasive cardiac implant for symptomatic heart failure (HF) patients with an EF≥40%.
- First therapeutic device designed to directly address elevated left atrial pressure (LAP), the primary contributor of HF symptoms
- Provides continuous and dynamic LAP reduction at any activity level
- Only requires short term dual antiplatelet therapy
- Treatment is less reliant on compliance with medication and diet (a recent study revealed that almost half of HF patients are non-compliant with their prescribed medications)1
- Therapy is not dependent upon daily pressure monitoring

INTELLIGENTLY-DESIGNED FOR IMMEDIATE RESULTS THAT LAST


8mm shunt diameter
Clinically validated, optimized decompression

Reinforced barrel
Maintains shunt patency

Non-thrombogenic design
Flat LA profile promotes
rapid endothelialization

Adjustable RA legs
Accommodate varied septal wall thickness

Preserves therapy options
8mm inner diameter and
low profile avoids barriers
to future therapies
- Wu JR, Moser DK. Medication Adherence Mediates the Relationship Between Heart Failure Symptoms and Cardiac Event-Free Survival in Patients With Heart Failure. J Cardiovasc Nurs. 2018;33(1):40-46.